Comparison between in-phase and opposed-phase T1-weighted breath-hold FLASH sequences for hepatic imaging

Journal of Computer Assisted Tomography

Volumn 20, Issue 2, 1996, Pages 230-235

  Rofsky, Neu M ^a,b   Weinreb, Jeffrey C ^a   Ambrosino, Michael M ^a   Safir, Julian ^a   Krinsky, Glenn ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chemical shift imaging; Liver; Liver, cirrhosis; Liver, neoplasms; Magnetic resonance imaging, rapid; Magnetic resonance imaging, techniques

Indexed keywords

CHEMICAL SHIFT; DIAGNOSIS; IMAGE ENHANCEMENT;

BREATH-HOLD; CHEMICAL SHIFT IMAGING; IN-PHASE; LIVER CIRRHOSIS; LIVER LESIONS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING, RAPID; MAGNETIC RESONANCE IMAGING, TECHNIQUE; NOISE RATIO; PHASE SEQUENCE;

MAGNETIC RESONANCE IMAGING;

ADULT; ARTICLE; BREATH HOLDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FATTY LIVER; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER CANCER; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIGNAL NOISE RATIO;

EID: 0029872618     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-199603000-00012     Document Type: Article

References (11)

1. Wehrli FW, Perkins TG, Shimakawa A, Roberts F. Chemical shift-induced amplitude modulations in images obtained with gradient refocusing. Magn Reson Imag 1987;5:157-8.
2. Rosen LR, Carter MA, Pyket LL. Proton chemical shift imaging: an evaluation of its clinical potential using in vivo fatty liver model. Radiology 1985;154:469-72.
3. Mitchell DG, Kim I, Chang TS, et al. Fatty liver: chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans. Invest Radiol 1991;26:1041-52.
4. Low RN, Francis IR, Sigeti JS, Foo TK. Abdominal MR imaging: comparison of T2-weighted fast and conventional spin-echo, and contrast-enhanced fast multiplanar spoiled gradient-recalled imaging. Radiology 1993;186:803-11.
5. Semelka RC, Simm FC, Recht M, Deimling M, Lenz G, Laub GA. T1-weighted sequences for MR imaging of the liver: comparison of three techniques for single-breath, whole-volume acquisition at 1.0 and 1.5 T. Radiology 1991; 180:629-35.
6. Hendrick RE, Raff U. Image contrast and noise. In: Stark DD, Bradley WG, eds. Magnetic resonance imaging, vol 1. 2nd ed. St. Louis: Mosby-Year Book, 1992:138-44.
7. Levenson H, Greensite G, Hoefs J, et al. Fatty infiltration of the liver: quantification with phase contrast MR imaging at 1.5 T vs. biopsy. AJR 1991;156:307-12.
8. Sugarbaker PH. Surgical decision making for large bowel cancer metastatic to the liver. Radiology 1990;174:621-6.
9. Schertz LD, Lee JKT, Heiken JP, Molina PL, Totty WG. Proton spectroscopic imaging (Dixon method) of the liver: clinical utility. Radiology 1989;173:401-5.
10. Leroy-Willig A, Roucayrol JC, Luton JP, et al. In vitro adrenal cortex lesions: characterization by NMR spectroscopy. Magn Reson Imag 1987;5:339-44.
11. Mitchell DG, Crovello M, Matteuchi T, Peterson RO, Miettienen MM. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 1992;185:345-51.